资讯
In CAR T-cell therapy for diffuse large B-cell lymphoma, distinct archetypes could guide personalized treatment decisions.
Dubai, United Arab Emirates; June, 2025 - Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic ...
The blood cancer multiple myeloma is deadly. This disease is personal for us because one of our best friends and colleagues ...
Kennedy researchers have uncovered key design parameters for bispecific T-cell engagers (TcEs)—a class of cancer ...
Analysis revealed that patients with T-cell exhausted archetype tumors had significantly higher rates of progressive disease ...
Jacob E. Berchuck, MD, discusses research on plasma epigenomic profiling in metastatic castration-resistant prostate cancer.
In India, two cancer patients treated with CAR T therapy have survived three years in one of the longest follow-ups in South ...
CLOVIS, Calif. (KFSN) -- For the first time, a potential cancer cure is being offered here in Central California. Action News ...
3 天
News-Medical.Net on MSNNew switchable CAR-T therapy enters phase 1 trial for advanced breast cancerThe Calibr-Skaggs Institute for Innovative Medicines, the drug development division of Scripps Research, today announced a ...
5 天
ZME Science on MSNCAR T Breakthrough Therapy Doubles Survival Time for Deadly Stomach CancerThe cure to cancer may not be hidden in some drug or chemical but within our own body. A team of Chinese researchers recently ...
Revolutionary advancements in blood cancer treatment, from targeted therapy to gene editing, promise more effective and ...
Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果